Chlorambucil
Showing 26 - 50 of 106
Chronic Lymphocytic Leukemia Trial in Austria, Germany (Fludarabine, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Fludarabine
- Chlorambucil
-
Vienna, Austria
- +87 more
May 21, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Chlorambucil, Obinutuzumab)
Terminated
- Chronic Lymphocytic Leukemia
- Idelalisib
- +2 more
-
Santa Barbara, California
- +17 more
Oct 19, 2018
Chronic Lymphocytic Leukemia Trial in Worldwide (Fludarabine, Cyclophosphamide, Rituximab)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Fludarabine
- +6 more
-
Wien, Austria
- +160 more
Sep 29, 2021
Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- Obinutuzumab
- +2 more
-
Bad Saarow, Germany
- +29 more
May 4, 2022
Uveitis Trial in Worldwide (Adalimumab (ADA), Conventional immunosuppression (CON))
Recruiting
- Uveitis
- Adalimumab (ADA)
- Conventional immunosuppression (CON)
-
Los Angeles, California
- +27 more
Jun 16, 2022
B-Cell Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) Trial in Huixquilucan
Completed
- B-Cell Chronic Lymphocytic Leukemia
- B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)
- Ibrutinib
- +2 more
-
Huixquilucan, Estado De México, MexicoGrupo Cooperativo de Hemopatías Malignas
Feb 1, 2021
B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Chlorambucil)
Completed
- B-Cell Chronic Lymphocytic Leukemia
- Lenalidomide
- Chlorambucil
-
Escondido, California
- +164 more
Jun 14, 2019
Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- obinutuzumab
- +2 more
-
San Diego, California
- +261 more
Aug 15, 2018
Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)
Expression of CD19 Complex in Lymphoproliferative Disorders
Not yet recruiting
- Lymphoproliferative Disorders
- Flow cytometry
- (no location specified)
Feb 2, 2021
Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- obinutuzumab
- +2 more
-
San Diego, California
- +261 more
Aug 15, 2018
Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- obinutuzumab
- +2 more
-
San Diego, California
- +261 more
Aug 15, 2018
Waldenstrom's Macroglobulinemia Trial in Athens, Rotterdam, Salamanca (Bortezomib, Rituximab, Dexamethasone)
Completed
- Waldenstrom's Macroglobulinemia
- Bortezomib, Rituximab, Dexamethasone
-
Athens, Attica, Greece
- +3 more
Apr 27, 2021
Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)
Terminated
- Leukemia
- +3 more
- rhIL-15
- Obinutuzumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 11, 2022
Safety of Chlorambucil + Rituximab in CLL Patients
Unknown status
- CLL
- +4 more
-
Ascoli Piceno, Italy
- +19 more
Mar 21, 2018
Dermatomyositis, Adult Type Trial in New Orleans (Apremilast 30mg)
Completed
- Dermatomyositis, Adult Type
- Apremilast 30mg
-
New Orleans, LouisianaTulane University
Jul 7, 2021
Chronic Lymphocytic Leukemia- Binet Staging System Trial in Spain (Acalabrutinib 100 MG Oral Capsule)
Recruiting
- Chronic Lymphocytic Leukemia- Binet Staging System
- Acalabrutinib 100 MG Oral Capsule
-
A Coruña, Spain
- +20 more
Jan 17, 2022
Treatment Outcome of Uveitis in Autoimmune Diseases
Unknown status
- Autoimmune Uveitis
- Corticosteroid Series
- (no location specified)
Mar 20, 2019
Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Tumors Trial run by the NCI (75 approved agents, COXEN)
Completed
- Urothelial Carcinoma
- +2 more
- 75 approved agents
- COXEN
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 14, 2020
Chronic Lymphocytic Leukemia Trial in Brno, Hradec Králové
Unknown status
- Chronic Lymphocytic Leukemia
-
Brno, Czechia
- +1 more
Mar 15, 2019
Lymphocytic Leukemia, Chronic Trial in Italy (rituximab [MabThera/Rituxan], chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- rituximab [MabThera/Rituxan]
- chlorambucil
-
Catanzaro, Calabria, Italy
- +19 more
Jul 6, 2017
Idiopathic Membranous Nephropathy Trial in Shanghai (Tacrolimus, Prednisone)
Unknown status
- Idiopathic Membranous Nephropathy
-
Shanghai, Shanghai, ChinaShanghai Xinhua Hospital affliated to Shanghai Jiao Tong Univers
Apr 1, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Bendamustine, Chlorambucil, Cyclophosphamide)
Completed
- Chronic Lymphocytic Leukemia
- Bendamustine
- +4 more
-
Santa Fé, Argentina
- +173 more
Oct 24, 2019
Chronic Lymphocytic Leukemia Trial in United States (Obinutuzumab, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Obinutuzumab
- Chlorambucil
-
Huntsville, Alabama
- +18 more
Mar 20, 2017